company background image
AFP logo

AFT Pharmaceuticals ASX:AFP Stock Report

Last Price

AU$2.85

Market Cap

AU$297.3m

7D

0.7%

1Y

-10.4%

Updated

23 Apr, 2024

Data

Company Financials +

AFT Pharmaceuticals Limited

ASX:AFP Stock Report

Market Cap: AU$297.3m

AFP Stock Overview

AFT Pharmaceuticals Limited, together with its subsidiaries, engages in the development and sale of pharmaceutical products in New Zealand, Australia, Asia, and internationally.

AFP fundamental analysis
Snowflake Score
Valuation0/6
Future Growth3/6
Past Performance2/6
Financial Health5/6
Dividends0/6

AFT Pharmaceuticals Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for AFT Pharmaceuticals
Historical stock prices
Current Share PriceNZ$2.85
52 Week HighNZ$3.70
52 Week LowNZ$2.50
Beta0.23
1 Month Change3.64%
3 Month Change-19.26%
1 Year Change-10.38%
3 Year Change-22.55%
5 Year Change47.67%
Change since IPO-3.39%

Recent News & Updates

Recent updates

Shareholder Returns

AFPAU PharmaceuticalsAU Market
7D0.7%-4.8%-3.0%
1Y-10.4%30.9%3.9%

Return vs Industry: AFP underperformed the Australian Pharmaceuticals industry which returned 30.9% over the past year.

Return vs Market: AFP underperformed the Australian Market which returned 3.9% over the past year.

Price Volatility

Is AFP's price volatile compared to industry and market?
AFP volatility
AFP Average Weekly Movement10.0%
Pharmaceuticals Industry Average Movement10.9%
Market Average Movement8.9%
10% most volatile stocks in AU Market17.2%
10% least volatile stocks in AU Market3.4%

Stable Share Price: AFP has not had significant price volatility in the past 3 months.

Volatility Over Time: AFP's weekly volatility (10%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1997100Hartley Atkinsonwww.aftpharm.com

AFT Pharmaceuticals Limited, together with its subsidiaries, engages in the development and sale of pharmaceutical products in New Zealand, Australia, Asia, and internationally. It offers products for use in the areas of allergy, cold and flu, digestive health, eye care, first aid, nail care, oral care, pain management, skin care, and supplements, as well as other products. AFT Pharmaceuticals Limited was incorporated in 1997 and is headquartered in Auckland, New Zealand.

AFT Pharmaceuticals Limited Fundamentals Summary

How do AFT Pharmaceuticals's earnings and revenue compare to its market cap?
AFP fundamental statistics
Market capAU$297.32m
Earnings (TTM)AU$10.02m
Revenue (TTM)AU$160.12m

30.0x

P/E Ratio

1.9x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
AFP income statement (TTM)
RevenueNZ$174.51m
Cost of RevenueNZ$94.27m
Gross ProfitNZ$80.24m
Other ExpensesNZ$69.32m
EarningsNZ$10.92m

Last Reported Earnings

Sep 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)0.10
Gross Margin45.98%
Net Profit Margin6.26%
Debt/Equity Ratio49.8%

How did AFP perform over the long term?

See historical performance and comparison

Dividends

0.4%

Current Dividend Yield

7%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.